BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12620269)

  • 1. Extracorporeal photopheresis technical aspects.
    Schooneman F
    Transfus Apher Sci; 2003 Feb; 28(1):51-61. PubMed ID: 12620269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photochemotherapy: evaluation of two techniques and use in connective tissue disorders.
    Andreu G; Leon A; Heshmati F; Tod M; Menkes CJ; Baudelot J; Laroche L
    Transfus Sci; 1994 Dec; 15(4):443-54. PubMed ID: 10155563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control for the validation of extracorporeal photopheresis process using the Vilbert-Lourmat UV-A irradiation's system.
    Jacob MC; Manches O; Drillat P; Richard MJ; Plumas J; Chaperot L; Hegelhofer H; Garban F; Gressin R; Favrot M; Bensa JC; Pernollet M
    Transfus Apher Sci; 2003 Feb; 28(1):63-70. PubMed ID: 12620270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis as a treatment for patients with severe, refractory atopic dermatitis.
    Sand M; Bechara FG; Sand D; Radenhausen M; Tomi NS; Altmeyer P; Hoffmann K
    Dermatology; 2007; 215(2):134-8. PubMed ID: 17684376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photopheresis in pediatric patients with low-body weight using the UVAR XTS system.
    Hillen U; Meyer S; Schadendorf D; Kremens B
    J Dtsch Dermatol Ges; 2010 Jan; 8(1):32-7. PubMed ID: 19751224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
    Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
    Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of a new, single, integrated, closed photopheresis system in patients with cutaneous T-cell lymphoma.
    Bisaccia E; Vonderheid EC; Geskin L
    Br J Dermatol; 2009 Jul; 161(1):167-9. PubMed ID: 19298276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical comparison of four different extracorporeal photopheresis systems.
    Brosig A; Hähnel V; Orsó E; Wolff D; Holler E; Ahrens N
    Transfusion; 2016 Oct; 56(10):2510-2519. PubMed ID: 27456672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and flow cytometry outcome of improved photopheresis methods in dermatologic patients].
    Ullrich H; Stolz W; Barlage S; Lackner KJ; Rothe G; Schmitz G
    Beitr Infusionsther Transfusionsmed; 1997; 34():256-64. PubMed ID: 9417345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodegradation of folic acid during extracorporeal photopheresis.
    Der-Petrossian M; Födinger M; Knobler R; Hönigsmann H; Trautinger F
    Br J Dermatol; 2007 Jan; 156(1):117-21. PubMed ID: 17199577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and immunological aspects of extracorporeal photochemotherapy for psoriasis and psoriatic arthritis].
    Molochkov VA; Kil'diushevskiĭ AV; Molochkov AV; Karzanov OV; Iakubovskaia ES; Fedulkina VA
    Ter Arkh; 2012; 84(10):69-74. PubMed ID: 23227505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular aspects of extracorporeal photochemotherapy.
    Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
    Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracorporeal photochemotherapy for treatment of clonal T cell proliferations].
    Plumas J; Drillat P; Jacob MC; Richard MJ; Favrot MC
    Bull Cancer; 2003; 90(8-9):763-70. PubMed ID: 14609767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of extracorporeal photochemotherapy.
    Heshmati F
    Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cell death after treatment with extracorporeal photopheresis.
    Daniele N; Del Proposto G; Cerrone P; Sinopoli S; Sansone L; Gadaleta DI; Lanti A; Ferraro AS; Spurio S; Scerpa MC; Zinno F; Adorno G; Isacchi G
    Transfus Apher Sci; 2012 Feb; 46(1):53-7. PubMed ID: 22138605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
    Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
    Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
    Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
    Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C; Shah K; Dynis M; Eby CS; Grossman BJ
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new device to study ex-vivo the effects of extracorporeal photochemotherapy on the immune system.
    Rigolio R; Perseghin P; Jonsson S; Petersson J; Cavaletti G; Cilio CM
    J Photochem Photobiol B; 2007 Jul; 88(1):68-75. PubMed ID: 17583527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
    Laulhé M; Lefebvre S; Le Broc-Ryckewaert D; Pierre M; Ferry A; Delorme B
    PLoS One; 2019; 14(3):e0212835. PubMed ID: 30822323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.